signature 4 . This T reg -cell-specific pattern of hypomethylation of CpG dinucleotides particularly at the Foxp3 locus itself 5 , is an essential requirement for thymocytes to acquire T reg -cell-specific gene expression, lineage stability and full suppressive activity.
On the basis of those observations, it has become evident that the time point during thymocyte differentiation at which the T reg -cell-lineage 'choice' is initialized and what exact steps thymocytes undergo to establish the T reg cell fate have not been identified thus far. Data obtained through the study of hematopoietic or embryonic stem cells, however, have stimulated appreciation of epigenetic events as a foundation for subsequent 'decisions' individual cells will make during their differentiation toward mature somatic cells 6 and have suggested that the 'engraving' of the T reg cell program in the thymus could also be governed by mechanisms that induce a T reg -cell-specific epigenetic landscape.
Following the concept of predetermination of distinct lineage fate by an already established epigenetic landscape in pre-committed precursor cells, Kitagawa et al. now introduce a similar concept to thymocyte development and the commitment toward T reg cell differentiation 1 . Using extensive and comprehensive approaches to assess epigenetic and transcriptional regulation in peripheral T reg cells, they link the activity of a class of enhancers, the so-called 'super-enhancers' , suggested to control expression of the associated lineagespecifying genes in various cell types 7 , to the expression of several genes that define T reg cell identity, including Foxp3, Ctla4 and Il2ra.
On the basis of their identification of a group of T reg -cell-specific super-enhancers in peripheral T reg cells, Kitagawa et al. postulate that the establishment of these superenhancers could represent the aforementioned instructive upstream event necessary for the commitment of thymic T reg cell precursors to the T reg cell lineage fate 1 . Applying a broad set of genome-wide approaches to determine the epigenetic and transcriptional landscape of thymic populations of T reg cells and their precursors, they confirm their initial hypothesis that permissive remodeling of the epigenetic landscapes at this set of super-enhancers T he vast majority of regulatory T cells (T reg cells) are generated within the thymus. At a certain stage of development, thymocytes must make a 'decision' between the CD4 + -helper-T-cell fate and the acquisition of T reg cell properties. The T reg -cell-lineage-specifying transcription factor Foxp3 is vital for the generation of thymic T reg cells, and its loss results in the development of fatal autoimmunity through inadequate suppression of auto-reactive T cells. While the molecular signals required for the induction of Foxp3 expression have been widely studied over the past years, the instructive events that govern thymic T reg cell development and allow Foxp3 expression in a specific subpopulation of thymocytes have remained largely unknown. In the current issue of Nature Immunology, a study by Kitagawa et al. now establishes the concept of the induction of a permissive epigenetic landscape that allows the induction of thymic T reg cell programs 1 . This process, which precedes Foxp3 expression, is mediated by the chromatin organizer Satb1.
Published work has substantially increased knowledge of the molecular events that induce the development of T reg cells in the thymus via pre-committed T reg cell precursor states that can be reached via two separate and distinct ways of development 2, 3 . In common for both is increased signaling via the T cell antigen receptor (TCR) through high-affinity interactions, which, combined with additional (costimulatory) signals provided by the interaction with thymic epithelial and dendritic cells, is critical for the induction of Foxp3 expression. Notably, TCR stimulation has been found to be necessary not only for the induction of Foxp3 expression but also for the Foxp3-independent establishment of a T reg -cell-specific epigenetic epigenetic orchestration of thymic T reg cell development
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Regulatory T cells develop in the thymus as a distinct lineage of T cells instructed by the lineage-specifying transcription factor Foxp3. Epigenetic imprinting by the genome organizer Satb1 precedes this cell-fate 'decision' during thymocyte development.
is required for commitment to the T reg cell lineage, the induction of Foxp3 expression and fixation of the unique T reg -cell-specific phenotype by subsequent hypomethylation of T reg -cell-specific epigenetic signature genes ( Fig. 1) 1 .
But how are those T reg -cell-specific superenhancers activated during thymic T reg cell development? To address this question, Kitagawa et al. 1 again turn to analogies from the lineage commitment of other cell types, such as myeloid cells, for which transcription factors such as PU.1 have been described as pioneering factors required for alterations in the epigenetic landscape that allow subsequent expression of myeloid-lineage-specific genes 8 . Global organizers of chromatin with high expression in the respective cell type mainly exert this function. Satb1 has high expression during thymocyte development, and its activity has been introduced as a key event necessary for the generation of functional CD4 + or CD8 + single-positive thymocytes 9 , while its suppression in peripheral T reg cells is key for preventing the effector differentiation of mature T reg cells 10 . Thus far, Satb1 has been described functionally as a global genome organizer able to induce both transcriptional regulation and epigenetic regulation via the formation of longrange chromatin loops from base-unpairing regions, which thereby brings distal genes in close proximity 11 . In addition, Satb1 can recruit chromatin-remodeling and histonemodifying enzymes as well as transcription factors to Satb1-bound gene loci. Through the use of the comprehensive data set of thymic T reg cell precursor populations, Satb1 is presented as a possible upstream molecule of the T reg -cell-specific super-enhancer landscape 1 . From elegant knockout studies comparing the results of deletion of Satb1 at various stages of thymic T reg cell development, Kitagawa et al. conclude that the action of Satb1 is already necessary during early stages of thymic T reg cell development 1 . At this point, Satb1 can bind even to super-enhancers within closed chromatin, where chromatin accessibility, as measured by ATAC-seq (assay for transposase-accessible chromatin and high-throughput sequencing), is low. That finding leads to the conclusion that Satb1 might act as a pioneering factor for T reg nature immunology volume 18 number 2 February 2017 cell commitment through the selective priming of T reg -cell-specific super-enhancers.
Could those findings also alter the current understanding of induction of the lineage-specifying transcription factor Foxp3? To address this question, Kitagawa et al. 'fine-map' a super-enhancer containing the three pre-described conserved non-coding sequence elements (CNS1-CNS3) at the Foxp3 locus associated with enhancer activity important for the thymic and peripheral differentiation of T reg cells, as well as stability of Foxp3 expression 12 , and identify a previously unknown conserved element they call 'CNS0' that is bound by Satb1 already in a closed chromatin confirmation before the commitment of thymocytes to the T reg cell lineage 1 . They propose that this element, through binding of Satb1 and subsequent alterations in chromatin accessibility or histone modifications, acts as a pioneering element required for the subsequent activities of the other CNS elements that lead to the initiation of Foxp3 expression.
The current study adds another piece to the puzzle of the fascinating events that take place within the thymus and during specialization of thymocytes to the T reg cell lineage. Still, important questions remain open, including the intermediate factor or reaction that 'translates' the binding of Satb1 into final commitment to the T reg cell lineage, as binding of Satb1 alone is not sufficient to activate T reg -cell-specific superenhancers. Here, TCR signaling (as has been suggested by published evidence 4 ) could be the next step that further promotes T reg cell differentiation; however, additional events, including unique signals provided by thymic antigenpresenting cells (J.H., unpublished data), might be required for the full commitment of cells to the T reg cell lineage. Furthermore, it is only incompletely understood how the activity and specificity of TET enzymes that enforce hypomethylation of CpG dinucleotides in Satb1-bound regions or stretches of DNA marked by notyet-identified intermediates is controlled on a molecular level and leads to the final epigenetic fixation of T reg -cell-lineage fate.
In addition, the current study also raises another set of questions that focus on the possible upstream mechanism that induces Satb1 expression. How is Satb1 expression 'translated' into binding at specific superenhancers? Is this a pre-committed event, for example, dependent on the three-dimensional configuration of chromatin or close association within topologically associating domains, or is this, alternatively, a rather stochastic event induced by testing of certain differentiation programs within the developing thymocyte? It will be fascinating to follow how these key questions are addressed in future studies and which of these possibilities will crystalize as the 'preferred' pathway of commitment to the T reg cell lineage.
One very practical implication of this study could be the translation of its findings into novel approaches to improve the therapeutic use of T reg cells for clinical applications. If the stability and commitment of T reg cells is induced by fixation through epigenetic modifications at T reg -cell-specific super-enhancers dependent on Satb1, then this could provide a vital lesson for the generation and quality control of T reg cell products used for transfusion into patients with autoimmune disease, graftversus-host disease after stem-cell transplantation or chronic graft rejection after solid-organ transplantation, to prevent loss of T reg cell identity after transfer.
In summary, the study by Kitagawa et al. has altered the current view of commitment to the T reg cell lineage within the thymus, extending it to an early, Satb1-dependent epigenetic imprinting of lineage identity at T reg -cellspecific super-enhancers, which allows T reg cells to stably exert their unique immunosuppressive properties in a long-lasting manner.
COMPETING FINANCIAL INTERESTS
The authors declare no competing financial interests. T he spliceosome mediates the alternative splicing of exons within pre-mRNA and is thus important for the generation of diversity in the proteome and for determining transcript abundance 1 . Many components of the spliceosome have been linked to hematological malignancies and myelodysplastic syndromes (MDSs). The latter exhibit expansion of immature proliferating myeloid cells and frequently transform into acute myeloid leukemia. Although mutations that affect the spliceosome in MDS alter the splicing of many RNAs, understanding of which of these give advantage to premalignant clones is only just beginning 2 . Moreover, how alternative splicing is connected to other processes in MDSs, such as signal transduction, is not known. In this issue of Nature Immunology, Fang et al. show that increased expression of the E3 ubiquitin ligase TRAF6 in hematopoietic stem cells results in alternative splicing changes that are regulated through TRAF6-mediated ubiquitination of the RNA-binding protein (RBP) hnRNP-A1, a component of the spliceosome 3 . They identify aberrant processing of pre-mRNAs encoding GTPase-activating proteins (GAPs) that leads to excessive activity of the GTP-binding protein (small G protein) Cdc42 that is detrimental to hematopoietic stem cells and results in an MDS-like phenotype (Fig. 1) .
Aberrant activation of Toll-like receptor (TLR) pathways is frequent in hematopoietic malignancies 4 . TLRs have been linked to the early development of hematopoietic stem cells, but chronic TLR signaling diminishes their capacity for self-renewal and promotes the skewing of differentiation into the myeloid lineage, a phenotype reminiscent of aging and MDSs. These effects involve TLR signaling in stem cells themselves but also reflect indirect effects of TLRs on the stem-cell environmentfor example, influences on the cytokine milieu. TRAF6 can mediate signal transduction by TLRs via conjugation of Lys63 of ubiquitin to target proteins (K63-linked ubiquitination). This form of ubiquitination does not lead to protein degradation but promotes altered function of the ubiquitinated protein and has been shown to be essential in the activation of transcription factor NF-κB and mitogen-activated protein kinase pathways. TRAF6 is emerging as a mediator of aberrant signaling in MDSs and might offer a therapeutic target for these syndromes 5 . However, it is not clear what the relevant TRAF6 targets in MDSs are.
Fang and colleagues explore the role of TRAF6 in hematopoietic cells and discover previously unknown TRAF6 targets relevant to MDSs 3 . They show that the ability of a TRAF6-expressing retrovirus to promote myeloid skewing of hematopoietic stem cells in vivo and diminish colony formation in vitro depends on the E3 ligase activity of TRAF6. They generate mice with transgenic expression of TRAF6 under the control of regulatory elements of the hematopoietic-compartmentspecific gene Vav1 (Vav-TRAF6) 3 . These mice have slightly higher TRAF6 expression in hematopoietic cells than that of control mice, but adult Vav-TRAF6 mice succumb to an MDS-like bone-marrow-failure syndrome, and hematopoietic stem cells from these mice compete poorly with their wild-type counterparts when transferred together into wild-type host mice in vivo 3 .
To detect target proteins that are ubiquitinated by TRAF6, Fang et al. perform a ubiquitin-capture proteomics screen comparing the parental human leukemia cell line TF1 with a variant depleted of TRAF6 through the use of small interfering RNA 3 . The group of target proteins shows enrichment for proteins involved in spliceosome function, relative to the abundance of proteins with other functions, and the authors single out the RBP hnRNP-A1 for further study. hnRNP-A1 has been linked to various stages of RNA biology, including transcription, splicing, nuclear export, translation, selective microRNA processing and RNA decay 6 . It has also been linked to telomere maintenance. Notably, knockdown of hnRNP-A1 in lineage-marker-negative (Lin -) Vav-TRAF6 mouse bone-marrow stem and progenitor cells reverses the diminished colony formation in vitro and repopulation potential in vivo 3 .
Analysis of gene expression in LinSca1 + cKit + Vav-TRAF6 progenitor cells through the use of an exon-specific microarray platform identifies many differences in splicing relative to that in wild-type cells 3 . In particular, increased skipping of exon 2 in Arhgap1 mRNA is interesting, because an Arhgap1-null allele in mice results in an MDS-like phenotype 7 . Arhgap1 is a GAP that promotes inactivation of Cdc42 by stimulating its GTPase activity and its transition to the inactive, GDP-bound state. Arhgap1, which is 439 amino acids in length, is translated from codons in exons 4-15. The authors find that exon 1 of Arhgap1 contains an upstream open reading frame that terminates at a stop codon in exon 2 when it is included 3 . This open reading frame seems to diminish translation from the downstream open reading frame that encodes Arhgap1. In contrast, when exon 2 is absent from the mRNA, an Arhgap1 protein with a 40-amino-acid amino-terminal extension should be generated. The authors observe less Arhgap1 protein in Lin -bone-marrow
